Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › N-phenpropylcyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase

N-phenpropylcyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase

US Patent 6660756 · Granted Dec 9, 2003

Estimated economic value: $301,764,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds useful as inhibitors of ATR kinase2025
Splicing modulator antibody-drug conjugates and methods of use2024
Splicing modulator antibody-drug conjugates and methods of use2024
Certain pladienolide compounds and methods of use2024
Certain aryl pladienolide compounds and methods of use2023
Small molecule modulators of human sting2023
Compounds useful as inhibitors of ATR kinase2022
Splicing modulator antibody-drug conjugates and methods of use2022
Compounds useful as inhibitors of ATR kinase2021
Compounds useful as inhibitors of ATR kinase2020
4-(biphen-3-yl)-1H-pyrazolo[3,4-c]pyridazine derivatives of formula (I) as GABA 2020
Geminal substituted aminobenzisoxazole compounds as agonists of α7-nicotinic ace2019